GlassScriptPhysician profile
Jared E Freedman
NPI 1063031334
$1,730.04
in general payments reported to CMS, 2019-2025
15 companies · $680 in 2025
The $680 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.68 · 2022: $193 · 2023: $222 · 2024: $615 · 2025: $680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,242 · Consulting Fee: $225 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,242.08 |
| Consulting Fee | $225.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $449.34 | 2022-2025 | Biotrue One Day, Infuse, Miebo |
| Coopervision INC. | $288.34 | 2022-2025 | Myday Contact Lens, Clariti Contact Lens |
| Tarsus Pharmaceuticals, INC. | $255.60 | 2024-2025 | Xdemvy |
| Abbvie INC. | $136.13 | 2022-2024 | |
| Sun Pharmaceutical Industries INC. | $107.78 | 2022-2024 | Cequa |
| Johnson & Johnson Vision Care, INC. | $100.58 | 2022-2025 | Acuvue |
| Alcon Vision LLC | $66.95 | 2024-2025 | Air Optix, Total30 |
| Dompe US, INC. | $66.42 | 2025 | Oxervate |
| Astellas Pharma US INC | $60.52 | 2024 | Izervay |
| Biotissue Holdings INC. | $57.01 | 2024-2025 | |
| Oyster Point Pharma, INC. | $43.52 | 2024 | Tyrvaya |
| Thea Pharma INC. | $41.45 | 2024-2025 | Iyuzeh |
| Johnson & Johnson Surgical Vision, INC. | $20.24 | 2024 | Lipiflow System Activator (Disposable) |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $19.68 | 2020 | |
| Amgen INC. | $16.48 | 2025 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Freedman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.